biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Hobberson Jun 11, 2014 11:48am

181 Views

Post# 22649462

RE:I have have predicting "stupid days" for 2 years...

jd,

I picked up another 2k this morning and noticed that the volume shown stayed the same and did not tick up by the 2k. Still hasn't. This also happened the other day, which makes me wonder if there are more shares being traded on other exchanges, including some of the dark ones, and more interest in BTI than we think. Just wondering.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!